The plant-based technology company, Calyxt, has appointed Yves Ribeill as the executive board chair. Ribeill will serve in this role while Calyxt goes through its search for a new CEO. Jim Blome has been in that role for the past two-and-a-half years and is leaving to pursue other opportunities. Blome previously served as president and CEO of Bayer CropScience and executive vice president and chief operating officer for Valent USA. Based in Roseville, Minnesota, Calyxt is considered a global leader in plant gene editing technology.
